SRx Health Solutions Inc. (SRXH) Financial Ratios
2 years of historical data (2022–2023) · Healthcare · Drug Manufacturers - General
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
1.20
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
N/A
—
5yr avg: -264.1%
30Y Low-264%·High-264%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SRXH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
SRx Health Solutions Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 1.2x P/FCF.
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Market Cap | $1M | — | — |
| Enterprise Value | $29M | — | — |
| P/E Ratio → | -0.17 | — | — |
| P/S Ratio | 0.02 | — | — |
| P/B Ratio | — | — | — |
| P/FCF | 1.20 | — | — |
| P/OCF | 0.67 | — | — |
P/E links to full P/E history page with 30-year chart
SRXH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| EV / Revenue | — | — | — |
| EV / EBITDA | — | — | — |
| EV / EBIT | — | — | — |
| EV / FCF | — | — | — |
SRXH Profitability
Margins and return-on-capital ratios measuring operating efficiency
SRx Health Solutions Inc. earns an operating margin of -4.9%. Operating margins have compressed from -1.3% to -4.9% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Gross Margin | 19.9% | 19.9% | 14.4% |
| Operating Margin | -4.9% | -4.9% | -1.3% |
| Net Profit Margin | -9.4% | -9.4% | -2.6% |
Return on Capital
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| ROE | — | — | -264.1% |
| ROA | -22.4% | -22.4% | -7.0% |
| ROIC | -18.1% | -18.1% | -5.1% |
| ROCE | -98.8% | -98.8% | -9.1% |
SRXH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $37M ($39M total debt minus $2M cash).
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Debt / Equity | — | — | 19.25 |
| Debt / EBITDA | — | — | — |
| Net Debt / Equity | — | — | 17.46 |
| Net Debt / EBITDA | — | — | — |
| Debt / FCF | — | 23.68 | 5.17 |
| Interest Coverage | -2.83 | -2.83 | -1.55 |
SRXH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.38x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.67x to 0.38x over the past 3 years.
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Current Ratio | 0.38 | 0.38 | 0.67 |
| Quick Ratio | 0.30 | 0.30 | 0.49 |
| Cash Ratio | 0.03 | 0.03 | 0.08 |
| Asset Turnover | — | 1.84 | 2.66 |
| Inventory Turnover | 16.67 | 16.67 | 19.75 |
| Days Sales Outstanding | — | 21.66 | 13.32 |
SRXH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
SRx Health Solutions Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Dividend Yield | — | — | — |
| Payout Ratio | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Earnings Yield | — | — | — |
| FCF Yield | 83.1% | — | — |
| Buyback Yield | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | — | — |
| Shares Outstanding | — | $12M | $704183 |
Peer Comparison
Compare SRXH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SRXHYou | $1M | -0.2 | — | 1.2 | 19.9% | -4.9% | — | -18.1% | — |
 OPRX | $124M | 24.6 | 6.5 | 6.6 | 67.3% | 10.7% | 4.2% | 7.1% | 0.3 |
 HIMS | $7B | 50.3 | 42.7 | 89.6 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 PHVS | $2B | -10.2 | — | — | — | — | -41.2% | — | — |
 TDOC | $1B | -6.1 | 15.1 | 4.4 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 ALHC | $4B | -4932.4 | 77.1 | 33.0 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 CVS | $111B | 62.8 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 MCK | $92B | 29.2 | 18.7 | 17.6 | 3.5% | 1.2% | — | 540.6% | 1.5 |
 CAH | $44B | 28.7 | 16.0 | 23.6 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
 GDRX | $973M | 33.3 | 4.0 | 5.9 | 82.1% | 13.4% | 4.5% | 13.0% | 0.3 |
 AMWL | $129M | -1.3 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 2 years · Updated daily
See SRXH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SRXH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SRXH vs OPRX
Side-by-side business, growth, and profitability comparison vs OptimizeRx Corporation.
Start ComparisonSRXH — Frequently Asked Questions
Quick answers to the most common questions about buying SRXH stock.
What is SRx Health Solutions Inc.'s P/E ratio?
SRx Health Solutions Inc.'s current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Is SRXH stock overvalued?
Based on historical data, SRx Health Solutions Inc. is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are SRx Health Solutions Inc.'s profit margins?
SRx Health Solutions Inc. has 19.9% gross margin and -4.9% operating margin.